FP
HOWL icon

Financial Perspectives’s Werewolf Therapeutics HOWL Stock Holding History

Financial Perspectives’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.62K Hold
6,750
– – ﹤0.01% 580
2025
Q4 		$4.28K Hold
6,750
– – ﹤0.01% 596
2025
Q3 		$13.3K Hold
6,750
– – ﹤0.01% 487
2025
Q2 		$7.36K Hold
6,750
– – ﹤0.01% 539
2025
Q1 		$6.56K Hold
6,750
– – ﹤0.01% 546
2024
Q4 		$9.99K Hold
6,750
– – ﹤0.01% 506
2024
Q3 		$14.3K Hold
6,750
– – 0.01% 435
2024
Q2 		$16.5K Hold
6,750
– – 0.01% 405
2024
Q1 		$43.7K Hold
6,750
– – 0.02% 293
2023
Q4 		$26.1K Buy
6,750
+3,000
+80% +$7.66K 0.01% 350
2023
Q3 		$8.03K Buy
3,750
+2,500
+200% +$6.89K ﹤0.01% 473
2023
Q2 		$3.81K Hold
1,250
– – ﹤0.01% 537
2023
Q1 		$3.25K Buy
1,250
+1,000
+400% +$2.98K ﹤0.01% 549
2022
Q4 		$513 Hold
250
– – ﹤0.01% 642
2022
Q3 		$1.13K Hold
250
– – ﹤0.01% 622
2022
Q2 		$1.02K Hold
250
– – ﹤0.01% 630
2022
Q1 		$1.1K Hold
250
– – ﹤0.01% 635
2021
Q4 		$2.98K Hold
250
– – ﹤0.01% 550
2021
Q3 		$4.29K Hold
250
– – ﹤0.01% 538
2021
Q2 		$4.36K Buy
+250
New +$3.42K ﹤0.01% 557

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Financial Perspectives's HOWL Position: Q1 2026 in Review

Financial Perspectives held its Werewolf Therapeutics (HOWL) position steady in Q1 2026 at 6,750 shares worth $5.62K. The position accounts for ﹤0.01% of the portfolio, ranked #580.

Financial Perspectives first reported a position in HOWL in Q2 2021 and has held it in 20 quarters since. The position peaked at $43.7K in Q1 2024. 48 funds tracked by Wall St. Rank hold HOWL as of Q1 2026.

  • Financial Perspectives held 6,750 shares of Werewolf Therapeutics worth $5.62K as of Q1 2026.
  • Financial Perspectives left its Werewolf Therapeutics share count unchanged in Q1 2026.
  • Werewolf Therapeutics made up ﹤0.01% of Financial Perspectives's portfolio in Q1 2026, its #580 holding.
  • Financial Perspectives first reported a position in Werewolf Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • Financial Perspectives's Werewolf Therapeutics position peaked at $43.7K in Q1 2024.
  • 48 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q1 2026.

Based on Financial Perspectives's 13F filing for Q1 2026, filed 11 May 2026.